The Safelock AML project

Important results from the project

** Denna text är maskinöversatt ** This project has largely met objective and aim. Great progress has been made and much valuable data has been generated. The new superRCA technology has also been tested and evaluated by potential users in an operational environment.

Expected long term effects

** Denna text är maskinöversatt ** This project has essentially achieved the expected and desired effect. Large amounts of data have been generated and the outcome appears to strengthen the thesis of being able to follow patients to a greater extent through blood tests provided a more sensitive technique is used. The extent of this will be scientifically reviewed and published.

Approach and implementation

** Denna text är maskinöversatt ** The project previously suffered delays due to difficulties in finding samples required for one of the patient groups. This could then be solved through a collaboration with a biobank in Finland. In addition, work has progressed well despite the addition of new staff during the course of the project. The final analysis and publication work is somewhat delayed due to the large amount of data and the number of researchers involved.